We have recently begun acquiring a new position in Novo Nordisk. Click here for our investment thesis on NVO stock.

SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

The reason Novo Nordisk is losing patent protection is because it wouldn't pay a couple hundred bucks. In 2019, the Canadian patent office sent a letter saying it hadn't received Novo Nordisk's annual ...

With Britain set to be as hot as Barbados and Malibu in the coming days, medics have warned those taking revolutionary weight ...

LEXX Lexaria Bioscience Corp. (NASDAQ:LEXX) announced that it had completed its GLP-1-H25-5 study last week and reported ...

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...

Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those ...

Despite an increase in the prevalence of prescribing, only 0.5% of U.S. adolescents with obesity were prescribed an obesity ...

Completion of SAD/MAD trial marks advancement toward further clinical development of HT-4253 in Alzheimer's and other ...

CPAP was more preferred by providers as treatment for obstructive sleep apnea, while patients preferred tirzepatide.